# Novel Therapeutic Approach for Human T-cell Malignancies

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: Istituto Oncologico Veneto IRCCS · Condition: T-Cell Leukemia/Lymphoma, Adult

- Company: Istituto Oncologico Veneto IRCCS
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06600568

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.